162 related articles for article (PubMed ID: 31841120)
1. KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway.
Xiong M; Zhuang K; Luo Y; Lai Q; Luo X; Fang Y; Zhang Y; Li A; Liu S
Aging (Albany NY); 2019 Dec; 11(24):11905-11921. PubMed ID: 31841120
[TBL] [Abstract][Full Text] [Related]
2. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway.
Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C
Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240
[TBL] [Abstract][Full Text] [Related]
3. RING-Finger Protein 6 Amplification Activates JAK/STAT3 Pathway by Modifying SHP-1 Ubiquitylation and Associates with Poor Outcome in Colorectal Cancer.
Liang Q; Ma D; Zhu X; Wang Z; Sun TT; Shen C; Yan T; Tian X; Yu T; Guo F; Tang J; Lin Y; Chen H; Zhou C; Ge Z; Zhong M; Chen J; Liu Q; Wang Z; Fang JY; Chen H; Hong J
Clin Cancer Res; 2018 Mar; 24(6):1473-1485. PubMed ID: 29288235
[No Abstract] [Full Text] [Related]
4. Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells.
Wei X; Wang G; Li W; Hu X; Huang Q; Xu K; Lou W; Wu J; Liang C; Lou Q; Qian C; Liu L
Oncol Rep; 2014 Jan; 31(1):335-41. PubMed ID: 24253664
[TBL] [Abstract][Full Text] [Related]
5. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
6. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
[TBL] [Abstract][Full Text] [Related]
7. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2/STAT3 pathway.
He T; Cui J; Wu Y; Sun X; Chen N
Life Sci; 2019 Oct; 235():116799. PubMed ID: 31472144
[TBL] [Abstract][Full Text] [Related]
9. Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis.
Xue X; Ramakrishnan SK; Weisz K; Triner D; Xie L; Attili D; Pant A; Győrffy B; Zhan M; Carter-Su C; Hardiman KM; Wang TD; Dame MK; Varani J; Brenner D; Fearon ER; Shah YM
Cell Metab; 2016 Sep; 24(3):447-461. PubMed ID: 27546461
[TBL] [Abstract][Full Text] [Related]
10. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC.
Wang S; Zhang W
Tumour Biol; 2016 May; 37(5):6561-9. PubMed ID: 26638167
[TBL] [Abstract][Full Text] [Related]
12. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
Wang SW; Sun YM
Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
[TBL] [Abstract][Full Text] [Related]
13. FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway.
Li P; Huang T; Zou Q; Liu D; Wang Y; Tan X; Wei Y; Qiu H
J Immunol; 2019 May; 202(10):3065-3075. PubMed ID: 30979816
[TBL] [Abstract][Full Text] [Related]
14. OSMR gene effect on the pathogenesis of chronic autoimmune Urticaria via the JAK/STAT3 pathway.
Luo XY; Liu Q; Yang H; Tan Q; Gan LQ; Ren FL; Wang H
Mol Med; 2018 Jun; 24(1):28. PubMed ID: 30134804
[TBL] [Abstract][Full Text] [Related]
15. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
16. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA 452 regulates IL20RA-mediated JAK1/STAT3 pathway in inflammatory colitis and colorectal cancer.
Lamichhane S; Mo JS; Sharma G; Choi TY; Chae SC
Inflamm Res; 2021 Aug; 70(8):903-914. PubMed ID: 34283251
[TBL] [Abstract][Full Text] [Related]
18. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway.
Wang H; Fu Y
BMC Cancer; 2021 Jul; 21(1):871. PubMed ID: 34330232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]